Ionis Pharmaceuticals, Inc. (IONS)
NMS – Real Time Price. Currency in USD
56.72
+1.30 (2.35%)
Market open: Aug 12, 2026, 2:47 PM EDT
55.47
+0.05 (0.09%)
Previous after-hours: Aug 11, 2026, 7:53 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
56.72
+1.30 (2.35%)
Market open: Aug 12, 2026, 2:47 PM EDT
55.47
+0.05 (0.09%)
Previous after-hours: Aug 11, 2026, 7:53 PM EDT
No Data
There are no news for this stock.
Total debt $2.2B significantly exceeds cash reserves ($350.1M), raising financial stability concerns
Total current assets $2.5B exceed Total current liabilities $315.6M, highlighting excellent liquidity
Debt-to-equity ratio (5.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-4.6x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $549.5M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.89 | 6.05 | 10 | |
| Quick ratio | 7.73 | 5.63 | 10 | |
| Debt to Equity | 4.98 | 0.30 | 2.0 | |
| Debt to Assets | 0.73 | 1.04 | 2.0 | |
| Interest coverage | -4.62 | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 587M | 788M | 705M | 944M | 874M |
| Gross Profit | 551M | 756M | 672M | 915M | 836M |
| Operating Income | -410M | -354M | -475M | -382M | -595M |
| Net Income | -270M | -366M | -454M | -381M | -565M |
| EBITDA | -388M | -331M | -453M | -359M | -568M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 17.07 | -51.54 | 5.0 |
| Next quarter | 13.86 | 24.65 | 9.0 |
| Current year | -2.53 | -50.87 | 1.0 |
| Next year | 49.78 | 47.28 | 10 |
| Weighted average score | 6.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 8.88 | -23.89 | -23.2 | 167.45 | 4.5 |
| Y/Y | -40.72 | -192.78 | -198.56 | 295.19 | 3.3 |
| 3y average | 19.15 | -14.57 | -10.58 | -12.54 | 3.0 |
| 5y average | 8.21 | -158.66 | -157.58 | 132.77 | 4.5 |
| Weighted average score | 3.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Narrow | 4.0 |
| Intangible assets | Wide | 9.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 2.0 |
| Economies of scale | Narrow | 4.0 |
| Weighted average score | 5.0 | |